Development and provision of research tools and next-gen cell & gene therapies for the healthcare and research sectors.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
EmpCo Directive — September 27, 2026
We analyzed the websites of over 250,000 companies, including Bio‑Techne's, to extract CSR initiatives and communications containing risky environmental claims.
Greenwashing risk score + your position within your sector
+250,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: September 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
STEMCELL Technologies
A
Development and commercialization of reagents, tools, and services for life science research, including cell culture media, cell separation products, instruments, and training services for stem cell, immunology, cancer, regenerative medicine, and cellular therapy research.
RoslinCT
B
Contract development and manufacturing of advanced cell and gene therapies, including iPSC, gene-edited, and stem cell therapies for clinical and commercial use.
BioGrad
B
Clinical trials, biobanking, and production of advanced cell therapies (stem cell and CAR-T cell treatments) for various diseases.
Initiatives identified among leaders
Rapport annuel détaillant progrès et engagements en durabilité environnementale.
“Publication d'un rapport de durabilité détaillant ...” - STEMCELL TechnologiesRéduction des déchets cliniques et dangereux via réutilisation et meilleure séparation
“La société identifie que la majorité de son emprei...” - RoslinCTPartenariat pour améliorer les pratiques préanalytiques en biopsie liquide
“Adhésion au consortium BLOODPAC pour améliorer les...” - STEMCELL Technologies68% of similar organizations communicate on CSR issues
+668 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports